Biology Reference
In-Depth Information
[161] Ito T, Hanabuchi S, Wang YH, Park WR, Arima K, Bover L, et al. Two functional
subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity
2008;28:870-80.
[162] Chen Y, Shen S, Gorentla BK, Gao J, Zhong XP. Murine regulatory T cells contain
hyperproliferative and death-prone subsets with differential ICOS expression.
J Immunol 2012;188:1698-707.
[163] Thomson AW, Turnquist HR, Raimondi G. Immunoregulatory functions of mTOR
inhibition. Nat Rev Immunol 2009;9:324-37.
[164] Vu MD, Xiao X, Gao W, Degauque N, Chen M, Kroemer A, et al. OX40 costimulation
turns off Foxp3+ Tregs. Blood 2007;110:2501-10.
[165] Valzasina B, Guiducci C, Dislich H, Killeen N, Weinberg AD, Colombo MP.
Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity:
a novel regulatory role for OX40 and its comparison with GITR. Blood 2005;105:
2845-51.
[166] So T, Croft M. Cutting edge: OX40 inhibits TGF-beta- and antigen-driven conversion of
naive CD4 T cells into CD25+Foxp3+ T cells. J Immunol 2007;179:1427-30.
[167] McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M, et al.
CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a
functional role for the glucocorticoid-induced TNF receptor. [comment]. Immunity
2002;16:311-23.
[168] van Olffen RW, Koning N, van Gisbergen KP, Wensveen FM, Hoek RM, Boon L, et al.
GITR triggering induces expansion of both effector and regulatory CD4+ T cells in vivo.
J Immunol 2009;182:7490-500.
[169] Ji HB, Liao G, Faubion WA, Abadia-Molina AC, Cozzo C, Laroux FS, et al. Cutting edge:
the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates
regulatory T cell suppression. J Immunol 2004;172:5823-7.
[170] Bushell A, Wood K. GITR ligation blocks allograft protection by induced CD25+CD4+
regulatory T cells without enhancing effector T-cell function. Am J Transplant
2007;7:759-68.
[171] Stephens GL, McHugh RS, Whitters MJ, Young DA, Luxenberg D, Carreno BM, et al.
Engagement of glucocorticoid-induced TNFR family-related receptor on effector T
cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol
2004;173:5008-20.
[172] Amakawa R, Hakem A, Kundig TM, Matsuyama T, Simard JJ, Timms E, et al. Impaired
negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell
1996;84:551-62.
[173] Gerli R, Pitzalis C, Bistoni O, Falini B, Costantini V, Russano A, et al. CD30+ T cells in
rheumatoid synovitis: mechanisms of recruitment and functional role. J Immunol
2000;164:4399-407.
[174] Dai Z, Li Q, Wang Y, Gao G, Diggs LS, Tellides G, et al. CD4+CD25+ regulatory T cells
suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent
mechanism. J Clin Invest 2004;113:310-7.
[175] Zhang ZX, Yang L, Young KJ, DuTemple B, Zhang L. Identification of a previously un-
known antigen-specific regulatory T cell and its mechanism of suppression. Nat Med
2000;6:782-9.
[176] de Kleer I, Vercoulen Y, Klein M, Meerding J, Albani S, van der Zee R, et al. CD30
discriminates heat shock protein 60-induced FOXP3+ CD4+ T cells with a regulatory
phenotype. J Immunol 2010;185:2071-9.
[177] Zeiser R, Nguyen VH, Hou JZ, Beilhack A, Zambricki E, Buess M, et al. Early CD30
signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in preven-
tion of acute graft-versus-host disease. Blood 2007;109:2225-33.
[178] Zheng G, Wang B, Chen A. The 4-1BB costimulation augments the proliferation of
CD4+CD25+ regulatory T cells. J Immunol 2004;173:2428-34.
[179] Hippen KL, Harker-Murray P, Porter SB, Merkel SC, Londer A, Taylor DK, et al. Umbili-
cal cord blood regulatory T-cell expansion and functional effects of tumor necrosis
factor receptor family members OX40 and 4-1BB expressed on artificial antigen-
presenting cells. Blood 2008;112:2847-57.
[180] Choi BK, Bae JS, Choi EM, Kang WJ, Sakaguchi S, Vinay DS, et al. 4-1BB-dependent
inhibition of immunosuppression by activated CD4+CD25+ T cells. J Leukocyte Biol
2004;75:785-91.
[181] Elpek KG, Yolcu ES, Franke DD, Lacelle C, Schabowsky RH, Shirwan H. Ex vivo expan-
sion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB
signaling. J Immunol 2007;179:7295-304.
[182] Sakoda Y, Park JJ, Zhao Y, Kuramasu A, Geng D, Liu Y, et al. Dichotomous regulation of
GVHD through bidirectional functions of the BTLA-HVEM pathway.
Blood 2011;117:2506-14.
222
Search WWH ::




Custom Search